Overview

A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults

Status:
Completed

Trial end date:
2019-03-12

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of a single oral dose of cyclosporine on the pharmacokinetics of a single oral dose of pimodivir when coadministered to healthy adult participants under fasted conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Janssen-Cilag International NV

Treatments:

Cyclosporine
Cyclosporins
Krestin